0001773558-19-000001.txt : 20190415 0001773558-19-000001.hdr.sgml : 20190415 20190415103748 ACCESSION NUMBER: 0001773558-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190415 DATE AS OF CHANGE: 20190415 EFFECTIVENESS DATE: 20190415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vaporox, Inc. CENTRAL INDEX KEY: 0001773558 IRS NUMBER: 811586753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337269 FILM NUMBER: 19747811 BUSINESS ADDRESS: STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 435 CITY: DENVER STATE: CO ZIP: 80216 BUSINESS PHONE: 303-558-5145 MAIL ADDRESS: STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 435 CITY: DENVER STATE: CO ZIP: 80216 D 1 primary_doc.xml X0708 D LIVE 0001773558 Vaporox, Inc. 3513 Brighton Blvd, Suite 435 Denver CO COLORADO 80216 303-558-5145 DELAWARE None None Corporation true Alan Sage 1196 S. Lincoln St. Denver CO COLORADO 80210 Executive Officer Director Promoter Louis Woodhill 2473 N. Field Street Dallas TX TEXAS 75201 Director Alex Goldstein 1800 Ocean Drive #2603 Hallandale Beach FL FLORIDA 33009 Director Biotechnology No Revenues 06b false 2019-03-25 false true false 5485 not applicable None None None not applicable not applicable CO COLORADO 80216 CO COLORADO false Indefinite 470000 Indefinite The total offering amount is undetermined at this point in time. The total amount sold to date is $470,000. false 5 0 0 The corporation is not planning to pay any co sales commissions or finders' fees. 300000 Directors loaned the corporation $300,000 during the period of Jan - March, 2019 for working capital while the terms of the offering were being prepared. false Vaporox, Inc. Alan Sage Alan Sage CEO/President 2019-04-15